Heart rate variability in myocardial infarction and heart failure

International Journal of Cardiology

Volumn 120, Issue 3, 2007, Pages 289-296

  Chattipakorn, Nipon ^a,b   Incharoen, Tanat ^a,b   Kanlop, Natnicha ^a,b   Chattipakorn, Siriporn ^a,b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Arrhythmia; Heart failure; Heart rate variability; Implantable cardioverter defibrillator; Myocardial infarction

Indexed keywords

CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DISEASE MARKER; DISEASE SEVERITY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; MORTALITY; NONHUMAN; NONLINEAR SYSTEM; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTEMATIC REVIEW; TECHNIQUE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION;

EID: 34447501687     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.221     Document Type: Review

References (104)

1. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324 (1991) 781-788
2. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
3. Welty F.K., Mittleman M.A., Lewis S.M., et al. A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction < 50%. Circulation 93 (1996) 1496-1501
4. Pratt C.M., Waldo A.L., and Camm A.J. Can antiarrhythmic drugs survive survival trials?. Am J Cardiol 81 (1998) 24D-34D
5. Coats A.J. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?. Int J Cardiol 82 (2002) 1-5
6. Kuch B., Bolte H.D., Hoermann A., Meisinger C., and Loewel H. What is the real hospital mortality from acute myocardial infarction? Epidemiological vs clinical view. Eur Heart J 23 (2002) 714-720
7. Zareba W. Implantable cardioverter defibrillator therapy in postinfarction patients. Curr Opin Cardiol 19 (2004) 619-624
8. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
9. Camm A.J., Pratt C.M., Schwartz P.J., et al. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 109 (2004) 990-996
10. Hadi H.A., Al Suwaidi J., Bener A., Khinji A., and Al Binali H.A. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar. Int J Cardiol 102 (2005) 249-254
11. Klein H.U., and Reek S. The MUSTT study: evaluating testing and treatment. J Interv Card Electrophysiol 4 Suppl 1 (2000) 45-50
12. Hon E.H., and Lee S.T. Electronic evaluations of the fetal heart rate pattern preceding fetal death, further observations. Am J Obstet Gynecol 87 (1965) 814-826
13. Ewing D.J., Martyn C.N., Young R.J., and Clarke B.F. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8 (1985) 491-498
14. Wolf M.M., Varigos G.A., Hunt D., and Sloman J.G. Sinus arrhythmia in acute myocardial infarction. Med J Aust 2 (1978) 52-53
15. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Berger A.C., and Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213 (1981) 220-222
16. Malik M., and Camm A.J. Components of heart rate variability-what they really mean and what we really measure. Am J Cardiol 72 (1993) 821-822
17. Zipes D.P., and Wellens H.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351
18. Shusterman V., Aysin B., Gottipaty V., et al. Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial. J Am Coll Cardiol 32 (1998) 1891-1899
19. Chiou C.W., and Zipes D.P. Selective vagal denervation of the atria eliminates heart rate variability and baroreflex sensitivity while preserving ventricular innervation. Circulation 98 (1998) 360-368
20. La Rovere M.T. Baroreflex sensitivity as a new marker for risk stratification. Z Kardiol 89 Suppl 3 (2000) 44-50
21. Malliani A., Pagani M., Lombardi F., and Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84 (1991) 482-492
22. Lombardi F., Malliani A., Pagani M., and Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc Res 32 (1996) 208-216
23. Bernardi L., Salvucci F., Suardi R., et al. Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise?. Cardiovasc Res 24 (1990) 969-981
24. Peng C.K., Havlin S., Stanley H.E., and Goldberger A.L. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos 5 (1995) 82-87
25. Bigger Jr. J.T., Steinman R.C., Rolnitzky L.M., Fleiss J.L., Albrecht P., and Cohen R.J. Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation 93 (1996) 2142-2151
26. Lombardi F. Chaos theory, heart rate variability, and arrhythmic mortality. Circulation 101 (2000) 8-10
27. Stein P.K., Domitrovich P.P., Huikuri H.V., and Kleiger R.E. Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction. J Cardiovasc Electrophysiol 16 (2005) 13-20
28. Saul J.P., Albrecht P., Berger R.D., and Cohen R.J. Analysis of long term heart rate variability: methods, 1/f scaling and implications. Comput Cardiol 14 (1988) 419-422
29. Seely A.J., and Macklem P.T. Complex systems and the technology of variability analysis. Crit Care 8 (2004) R367-R384
30. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93 (1996) 1043-1065
31. Merri M., Farden D.C., Mottley J.G., and Titlebaum E.L. Sampling frequency of the electrocardiogram for spectral analysis of the heart rate variability. IEEE Trans Biomed Eng 37 (1990) 99-106
32. Pinna G.D., Maestri R., Di Cesare A., Colombo R., and Minuco G. The accuracy of power-spectrum analysis of heart-rate variability from annotated RR lists generated by Holter systems. Physiol Meas 15 (1994) 163-179
33. Hejjel L., and Roth E. What is the adequate sampling interval of the ECG signal for heart rate variability analysis in the time domain?. Physiol Meas 25 (2004) 1405-1411
34. Carpeggiani C., Emdin M., Bonaguidi F., et al. Personality traits and heart rate variability predict long-term cardiac mortality after myocardial infarction. Eur Heart J 26 (2005) 1612-1617
35. Huikuri H.V., Makikallio T.H., Peng C.K., Goldberger A.L., Hintze U., and Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 101 (2000) 47-53
36. Stein P.K., Domitrovich P.P., Kleiger R.E., Schechtman K.B., and Rottman J.N. Clinical and demographic determinants of heart rate variability in patients post myocardial infarction: insights from the cardiac arrhythmia suppression trial (CAST). Clin Cardiol 23 (2000) 187-194
37. Malik M., Camm A.J., Janse M.J., Julian D.G., Frangin G.A., and Schwartz P.J. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol 35 (2000) 1263-1275
38. Lombardi F., Sandrone G., Pernpruner S., et al. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. Am J Cardiol 60 (1987) 1239-1245
39. Kleiger R.E., Miller J.P., Bigger Jr. J.T., and Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59 (1987) 256-262
40. Vaishnav S., Stevenson R., Marchant B., Lagi K., Ranjadayalan K., and Timmis A.D. Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol 73 (1994) 653-657
41. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., Mortara A., and Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351 (1998) 478-484
42. La Rovere M.T., Pinna G.D., Hohnloser S.H., et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 103 (2001) 2072-2077
43. Manfrini O., Pizzi C., Trere D., Fontana F., and Bugiardini R. Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction. Eur Heart J 24 (2003) 1560-1566
44. Balanescu S., Corlan A.D., Dorobantu M., and Gherasim L. Prognostic value of heart rate variability after acute myocardial infarction. Med Sci Monit 10 (2004) CR307-CR315
45. Bigger Jr. J.T., Fleiss J.L., Rolnitzky L.M., Steinman R.C., and Schneider W.J. Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol 18 (1991) 1643-1649
46. Grimm W., Herzum I., Muller H.H., and Christ M. Value of heart rate variability to predict ventricular arrhythmias in recipients of prophylactic defibrillators with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 26 (2003) 411-415
47. Lurje L., Wennerblom B., Tygesen H., Karlsson T., and Hjalmarson A. Heart rate variability after acute myocardial infarction in patients treated with atenolol and metoprolol. Int J Cardiol 60 (1997) 157-164
48. Kuch B., Parvanov T., Hense H.W., Axmann J., and Bolte H.D. Short-period heart rate variability in the general population as compared to patients with acute myocardial infarction from the same source population. Ann Noninvasive Electrocardiol 9 (2004) 113-120
49. Bigger Jr. J.T., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Kleiger R.E., and Rottman J.N. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 85 (1992) 164-171
50. Singh N., Mironov D., Armstrong P.W., Ross A.M., and Langer A. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries. Circulation 93 (1996) 1388-1395
51. Doulalas A.D., Flather M.D., Pipilis A., et al. Evolutionary pattern and prognostic importance of heart rate variability during the early phase of acute myocardial infarction. Int J Cardiol 77 (2001) 169-179
52. Carpeggiani C., L'Abbate A., Landi P., et al. Early assessment of heart rate variability is predictive of in-hospital death and major complications after acute myocardial infarction. Int J Cardiol 96 (2004) 361-368
53. Anderson J.L., and Horne B.D. Nonlinear heart rate variability: a better ECG predictor of cardiovascular risk?. J Cardiovasc Electrophysiol 16 (2005) 21-23
54. Saul J.P., Arai Y., Berger R.D., Lilly L.S., Colucci W.S., and Cohen R.J. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 61 (1988) 1292-1299
55. Musialik-Lydka A., Sredniawa B., and Pasyk S. Heart rate variability in heart failure. Kardiol Pol 58 (2003) 10-16
56. Aronson D., and Burger A.J. Gender-related differences in modulation of heart rate in patients with congestive heart failure. J Cardiovasc Electrophysiol 11 (2000) 1071-1077
57. Yoshikawa T., Baba A., Akaishi M., et al. Neurohumoral activations in congestive heart failure: correlations with cardiac function, heart rate variability, and baroreceptor sensitivity. Am Heart J 137 (1999) 666-671
58. Malave H.A., Taylor A.A., Nattama J., Deswal A., and Mann D.L. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 123 (2003) 716-724
59. Nolan J., Batin P.D., Andrews R., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98 (1998) 1510-1516
60. La Rovere M.T., Pinna G.D., Maestri R., et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107 (2003) 565-570
61. Anastasiou-Nana M.I., Terrovitis J.V., Athanasoulis T., et al. Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 96 (2005) 427-431
62. Aronson D., Mittleman M.A., and Burger A.J. Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure. Am J Cardiol 93 (2004) 59-63
63. Sandrone G., Mortara A., Torzillo D., La Rovere M.T., Malliani A., and Lombardi F. Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol 74 (1994) 340-345
64. Parker G.W., Michael L.H., Hartley C.J., Skinner J.E., and Entman M.L. Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs. Circ Res 66 (1990) 259-270
65. Bigger Jr. J.T., Rolnitzky L.M., Steinman R.C., and Fleiss J.L. Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy. J Am Coll Cardiol 23 (1994) 733-740
66. Zuanetti G., Latini R., Neilson J.M., Schwartz P.J., and Ewing D.J. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG). J Am Coll Cardiol 17 (1991) 604-612
67. Nogami Y., Takase B., Matsui T., et al. Effect of antiarrhythmic agents on heart rate variability indices after myocardial infarction: comparative experimental study of aprindine and procainamide. Biomed Pharmacother 59 Suppl 1 (2005) S169-S173
68. Krum H., Bigger Jr. J.T., Goldsmith R.L., and Packer M. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 25 (1995) 289-294
69. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 336 (1997) 525-533
70. Bonaduce D., Marciano F., Petretta M., et al. Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation 90 (1994) 108-113
71. Sacknoff D.M., Gleim G.W., Stachenfeld N., and Coplan N.L. Effect of athletic training on heart rate variability. Am Heart J 127 (1994) 1275-1278
72. Lazoglu A.H., Glace B., Gleim G.W., and Coplan N.L. Exercise and heart rate variability. Am Heart J 131 (1996) 825-826
73. Jensen-Urstad K., Saltin B., Ericson M., Storck N., and Jensen-Urstad M. Pronounced resting bradycardia in male elite runners is associated with high heart rate variability. Scand J Med Sci Sports 7 (1997) 274-278
74. Yataco A.R., Fleisher L.A., and Katzel L.I. Heart rate variability and cardiovascular fitness in senior athletes. Am J Cardiol 80 (1997) 1389-1391
75. Stein P.K., Ehsani A.A., Domitrovich P.P., Kleiger R.E., and Rottman J.N. Effect of exercise training on heart rate variability in healthy older adults. Am Heart J 138 (1999) 567-576
76. Schuit A.J., van Amelsvoort L.G., Verheij T.C., et al. Exercise training and heart rate variability in older people. Med Sci Sports Exerc 31 (1999) 816-821
77. Scott A.S., Eberhard A., Ofir D., et al. Enhanced cardiac vagal efferent activity does not explain training-induced bradycardia. Auton Neurosci 112 (2004) 60-68
78. Wu Z.K., Vikman S., Laurikka J., et al. Nonlinear heart rate variability in CABG patients and the preconditioning effect. Eur J Cardiothorac Surg 28 (2005) 109-113
79. Soares P.P., Moreno A.M., Cravo S.L., and Nobrega A.C. Coronary artery bypass surgery and longitudinal evaluation of the autonomic cardiovascular function. Crit Care 9 (2005) R124-R131
80. Wiggers H., Botker H.E., Egeblad H., Christiansen E.H., Nielsen T.T., and Molgaard H. Coronary artery bypass surgery in heart failure patients with chronic reversible and irreversible myocardial dysfunction: effect on heart rate variability. Cardiology 98 (2002) 181-185
81. Demirel S., Akkaya V., Oflaz H., Tukek T., and Erk O. Heart rate variability after coronary artery bypass graft surgery: a prospective 3-year follow-up study. Ann Noninvasive Electrocardiol 7 (2002) 247-250
82. Milicevic G., Fort L., Majsec M., and Bakula V. Heart rate variability decreased by coronary artery surgery has no prognostic value. Eur J Cardiovasc Prev Rehabil 11 (2004) 228-232
83. Singh N., Mironov D., Armstrong P.W., Ross A.M., and Langer A. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries. Circulation 93 (1996) 1388-1395
84. Kelly P.A., Nolan J., Wilson J.I., and Perrins E.J. Preservation of autonomic function following successful reperfusion with streptokinase within 12 h of the onset of acute myocardial infarction. Am J Cardiol 79 (1997) 203-205
85. Lind P., Hintze U., Moller M., and Mickley H. Thrombolytic therapy preserves vagal activity early after acute myocardial infarction. Scand Cardiovasc J 35 (2001) 92-95
86. Chakko S., Fernandez A., Sequeira R., Kessler K.M., and Myerburg R.J. Heart rate variability during the first 24 h of successfully reperfused acute myocardial infarction: paradoxic decrease after reperfusion. Am Heart J 132 (1996) 586-592
87. Zuanetti G., Neilson J.M., Latini R., Santoro E., Maggioni A.P., and Ewing D.J. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation 94 (1996) 432-436
88. Ryan T.J., Anderson J.L., Antman E.M., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 94 (1996) 2341-2350
89. Ryan T.J., Antman E.M., Brooks N.H., et al. Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 34 (1999) 890-911
90. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
91. Wranicz J.K., Rosiak M., Cygankiewicz I., Kula P., Kula K., and Zareba W. Sex steroids and heart rate variability in patients after myocardial infarction. Ann Noninvasive Electrocardiol 9 (2004) 156-161
92. Kawasaki T., Azuma A., Taniguchi T., et al. Heart rate variability in adult patients with isolated left ventricular noncompaction. Int J Cardiol 99 (2005) 147-150
93. Vigo D.E., Nicola S.L., Ladron De Guevara M.S., et al. Relation of depression to heart rate nonlinear dynamics in patients > or = 60 years of age with recent unstable angina pectoris or acute myocardial infarction. Am J Cardiol 93 (2004) 756-760
94. Malpas S.C. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Heart Circ Physiol 282 (2002) H6-H20
95. Schmidt G., Malik M., Barthel P., et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 353 (1999) 1390-1396
96. Bauer A., Kantelhardt J.W., Barthel P., et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 367 (2006) 1674-1681
97. Wichterle D., Melenovsky V., and Malik M. Mechanisms involved in heart rate turbulence. Card Electrophysiol Rev 6 (2002) 262-266
98. Wichterle D., Simek J., La Rovere M.T., Schwartz P.J., Camm A.J., and Malik M. Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction. Circulation 110 (2004) 1183-1190
99. Iravanian S., Arshad A., and Steinberg J.S. Role of electrophysiologic studies, signal-averaged electrocardiography, heart rate variability, T-wave alternans, and loop recorders for risk stratification of ventricular arrhythmias. Am J Geriatr Cardiol 14 (2005) 16-19
100. Klingenheben T., Ptaszynski P., and Hohnloser S.H. Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failure. J Cardiovasc Electrophysiol 16 (2005) 620-624
101. Verrier R.L., Kwaku K.F., Nearing B.D., and Josephson M.E. T-wave alternans: does size matter. J Cardiovasc Electrophysiol 16 (2005) 625-628
102. Tanno K., Ryu S., Watanabe N., et al. Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias: a prospective study using atrial pacing. Circulation 109 (2004) 1854-1858
103. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
104. Breithardt G., Cain M.E., el Sherif N., et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Circulation 83 (1991) 1481-1488